UniProt ID | AP1G1_HUMAN | |
---|---|---|
UniProt AC | O43747 | |
Protein Name | AP-1 complex subunit gamma-1 | |
Gene Name | AP1G1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 822 | |
Subcellular Localization |
Golgi apparatus . Cytoplasmic vesicle, clathrin-coated vesicle membrane Peripheral membrane protein Cytoplasmic side . Component of the coat surrounding the cytoplasmic face of coated vesicles located at the Golgi complex. |
|
Protein Description | Subunit of clathrin-associated adaptor protein complex 1 that plays a role in protein sorting in the late-Golgi/trans-Golgi network (TGN) and/or endosomes. The AP complexes mediate both the recruitment of clathrin to membranes and the recognition of sorting signals within the cytosolic tails of transmembrane cargo molecules.. | |
Protein Sequence | MPAPIRLRELIRTIRTARTQAEEREMIQKECAAIRSSFREEDNTYRCRNVAKLLYMHMLGYPAHFGQLECLKLIASQKFTDKRIGYLGAMLLLDERQDVHLLMTNCIKNDLNHSTQFVQGLALCTLGCMGSSEMCRDLAGEVEKLLKTSNSYLRKKAALCAVHVIRKVPELMEMFLPATKNLLNEKNHGVLHTSVVLLTEMCERSPDMLAHFRKLVPQLVRILKNLIMSGYSPEHDVSGISDPFLQVRILRLLRILGRNDDDSSEAMNDILAQVATNTETSKNVGNAILYETVLTIMDIKSESGLRVLAINILGRFLLNNDKNIRYVALTSLLKTVQTDHNAVQRHRSTIVDCLKDLDVSIKRRAMELSFALVNGNNIRGMMKELLYFLDSCEPEFKADCASGIFLAAEKYAPSKRWHIDTIMRVLTTAGSYVRDDAVPNLIQLITNSVEMHAYTVQRLYKAILGDYSQQPLVQVAAWCIGEYGDLLVSGQCEEEEPIQVTEDEVLDILESVLISNMSTSVTRGYALTAIMKLSTRFTCTVNRIKKVVSIYGSSIDVELQQRAVEYNALFKKYDHMRSALLERMPVMEKVTTNGPTEIVQTNGETEPAPLETKPPPSGPQPTSQANDLLDLLGGNDITPVIPTAPTSKPSSAGGELLDLLGDINLTGAPAAAPAPASVPQISQPPFLLDGLSSQPLFNDIAAGIPSITAYSKNGLKIEFTFERSNTNPSVTVITIQASNSTELDMTDFVFQAAVPKTFQLQLLSPSSSIVPAFNTGTITQVIKVLNPQKQQLRMRIKLTYNHKGSAMQDLAEVNNFPPQSWQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
29 | Ubiquitination | EEREMIQKECAAIRS HHHHHHHHHHHHHHH | 43.78 | - | |
29 | Acetylation | EEREMIQKECAAIRS HHHHHHHHHHHHHHH | 43.78 | 23236377 | |
37 | Phosphorylation | ECAAIRSSFREEDNT HHHHHHHHHCCCCCC | 20.62 | 17081983 | |
45 | Phosphorylation | FREEDNTYRCRNVAK HCCCCCCHHHHHHHH | 17.61 | 25839225 | |
55 | Phosphorylation | RNVAKLLYMHMLGYP HHHHHHHHHHHHCCC | 8.73 | 18083107 | |
61 | Phosphorylation | LYMHMLGYPAHFGQL HHHHHHCCCCHHCHH | 8.03 | 18083107 | |
76 | Phosphorylation | ECLKLIASQKFTDKR HHHHHHHCCCCCCCC | 27.23 | 26437602 | |
78 | Acetylation | LKLIASQKFTDKRIG HHHHHCCCCCCCCHH | 47.97 | 19608861 | |
78 | 2-Hydroxyisobutyrylation | LKLIASQKFTDKRIG HHHHHCCCCCCCCHH | 47.97 | - | |
78 | Ubiquitination | LKLIASQKFTDKRIG HHHHHCCCCCCCCHH | 47.97 | 19608861 | |
80 | Phosphorylation | LIASQKFTDKRIGYL HHHCCCCCCCCHHHH | 47.88 | 26437602 | |
104 | Phosphorylation | QDVHLLMTNCIKNDL HHHHHHHHHHHHCCC | 27.23 | 29083192 | |
144 | Ubiquitination | DLAGEVEKLLKTSNS HHHHHHHHHHHHCCH | 65.38 | 19608861 | |
144 | Acetylation | DLAGEVEKLLKTSNS HHHHHHHHHHHHCCH | 65.38 | 19608861 | |
147 | Malonylation | GEVEKLLKTSNSYLR HHHHHHHHHCCHHHH | 61.41 | 26320211 | |
147 | Ubiquitination | GEVEKLLKTSNSYLR HHHHHHHHHCCHHHH | 61.41 | - | |
147 | Acetylation | GEVEKLLKTSNSYLR HHHHHHHHHCCHHHH | 61.41 | 25953088 | |
148 | Phosphorylation | EVEKLLKTSNSYLRK HHHHHHHHCCHHHHH | 32.86 | 23403867 | |
149 | Phosphorylation | VEKLLKTSNSYLRKK HHHHHHHCCHHHHHH | 23.38 | 23403867 | |
151 | Phosphorylation | KLLKTSNSYLRKKAA HHHHHCCHHHHHHHH | 25.88 | 23403867 | |
152 | Phosphorylation | LLKTSNSYLRKKAAL HHHHCCHHHHHHHHH | 18.12 | 23403867 | |
156 | Ubiquitination | SNSYLRKKAALCAVH CCHHHHHHHHHHHHH | 32.24 | - | |
156 | 2-Hydroxyisobutyrylation | SNSYLRKKAALCAVH CCHHHHHHHHHHHHH | 32.24 | - | |
167 | Ubiquitination | CAVHVIRKVPELMEM HHHHHHHHCHHHHHH | 51.52 | - | |
180 | Ubiquitination | EMFLPATKNLLNEKN HHHHHHHHHHHHHCC | 47.94 | - | |
214 | Malonylation | DMLAHFRKLVPQLVR HHHHHHHHHHHHHHH | 53.55 | 26320211 | |
228 | Sulfoxidation | RILKNLIMSGYSPEH HHHHHHHHCCCCCCC | 2.61 | 31801345 | |
229 | Phosphorylation | ILKNLIMSGYSPEHD HHHHHHHCCCCCCCC | 27.82 | 24076635 | |
231 | Phosphorylation | KNLIMSGYSPEHDVS HHHHHCCCCCCCCCC | 17.47 | 24076635 | |
232 | Phosphorylation | NLIMSGYSPEHDVSG HHHHCCCCCCCCCCC | 27.60 | 24076635 | |
238 | Phosphorylation | YSPEHDVSGISDPFL CCCCCCCCCCCCHHH | 36.14 | 24076635 | |
263 | Phosphorylation | LGRNDDDSSEAMNDI HCCCCCCCHHHHHHH | 36.75 | 21406692 | |
264 | Phosphorylation | GRNDDDSSEAMNDIL CCCCCCCHHHHHHHH | 36.05 | 21406692 | |
276 | Phosphorylation | DILAQVATNTETSKN HHHHHHHHCCCCCCC | 43.76 | 21406692 | |
278 | Phosphorylation | LAQVATNTETSKNVG HHHHHHCCCCCCCHH | 35.96 | 21406692 | |
280 | Phosphorylation | QVATNTETSKNVGNA HHHHCCCCCCCHHHH | 42.85 | 21406692 | |
281 | Phosphorylation | VATNTETSKNVGNAI HHHCCCCCCCHHHHH | 18.92 | 21406692 | |
322 | Ubiquitination | RFLLNNDKNIRYVAL HHHHCCCCCHHHHHH | 57.29 | - | |
322 | Acetylation | RFLLNNDKNIRYVAL HHHHCCCCCHHHHHH | 57.29 | 25953088 | |
326 | Phosphorylation | NNDKNIRYVALTSLL CCCCCHHHHHHHHHH | 6.05 | 28152594 | |
331 | Phosphorylation | IRYVALTSLLKTVQT HHHHHHHHHHHHHHC | 32.33 | 24719451 | |
348 | Phosphorylation | NAVQRHRSTIVDCLK HHHHHHHHHHHHHHH | 19.16 | 27273156 | |
355 | Ubiquitination | STIVDCLKDLDVSIK HHHHHHHHCCCHHHH | 63.68 | - | |
362 | Ubiquitination | KDLDVSIKRRAMELS HCCCHHHHHHHHHHH | 28.46 | 21906983 | |
362 | 2-Hydroxyisobutyrylation | KDLDVSIKRRAMELS HCCCHHHHHHHHHHH | 28.46 | - | |
392 | Glutathionylation | LLYFLDSCEPEFKAD HHHHHHHCCHHHHHH | 11.46 | 22555962 | |
525 | Phosphorylation | STSVTRGYALTAIMK CCHHHHHHHHHHHHH | 8.64 | 7386487 | |
546 | Ubiquitination | CTVNRIKKVVSIYGS EEHHHHHHHHEEECC | 45.56 | 21906983 | |
549 | Phosphorylation | NRIKKVVSIYGSSID HHHHHHHEEECCCCC | 17.06 | 20860994 | |
566 | Phosphorylation | LQQRAVEYNALFKKY HHHHHHHHHHHHHHH | 10.11 | 28796482 | |
573 | Phosphorylation | YNALFKKYDHMRSAL HHHHHHHHHHHHHHH | 16.21 | 21253578 | |
757 | Phosphorylation | FQAAVPKTFQLQLLS HHHCCCCEEEEEECC | 15.56 | 28450419 | |
764 | Phosphorylation | TFQLQLLSPSSSIVP EEEEEECCCCCCCCC | 31.18 | 29496963 | |
766 | Phosphorylation | QLQLLSPSSSIVPAF EEEECCCCCCCCCCC | 33.08 | 29523821 | |
767 | Phosphorylation | LQLLSPSSSIVPAFN EEECCCCCCCCCCCC | 27.71 | 28450419 | |
768 | Phosphorylation | QLLSPSSSIVPAFNT EECCCCCCCCCCCCC | 31.76 | 28450419 | |
770 | Phosphorylation | LSPSSSIVPAFNTGT CCCCCCCCCCCCCCH | 2.78 | 24719451 | |
771 | Phosphorylation | SPSSSIVPAFNTGTI CCCCCCCCCCCCCHH | 29.48 | 27251275 | |
789 | Ubiquitination | IKVLNPQKQQLRMRI HHHHCHHHHHHHEEE | 41.07 | - | |
797 | Acetylation | QQLRMRIKLTYNHKG HHHHEEEEEEECCCC | 25.14 | 25953088 | |
799 | Phosphorylation | LRMRIKLTYNHKGSA HHEEEEEEECCCCCH | 19.78 | 24719451 | |
800 | Phosphorylation | RMRIKLTYNHKGSAM HEEEEEEECCCCCHH | 26.21 | 46164915 | |
802 | Phosphorylation | RIKLTYNHKGSAMQD EEEEEECCCCCHHHH | 25.99 | 24719451 | |
803 | Phosphorylation | IKLTYNHKGSAMQDL EEEEECCCCCHHHHH | 51.42 | 24719451 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of AP1G1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AP1G1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AP1G1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-144, AND MASS SPECTROMETRY. |